1/49
Looks like no tags are added yet.
Enteral
Drug administration via the GI tract
Parenteral
Any method of drug administration that does not involve the GI tract
IV, IM, SC
Requirements of parenteral dosage forms
Sterile - free from micro-organisms
Pyrogen free - free from fever inducing agents (LPS from bacteria)
When are parenterals given
When rapid action is needed
When patient is uncooperative, unconscious, or unable to accept or tolerate oral medications
When the drug is ineffective in other methods of administration
Types of parenteral routes
IV
Intraarterial: vasodilators for vasospasm
IM
SC
Intradermal: for allergen testing
Intrathecal: spinal canal for anesthesia
Intracardiac: adrenaline for resuscitation
Intraarticular: joints
Intraperitoneal: peritoneal dialysis
Intravesical: infusion into urinary bladder
IV
Fastest route of administration
Once administered it cannot be retrieved
Possibility of thrombus and embolus formation
Preparations must be isotonic (not suspensions)
Preparations must mix with blood and not precipitate
Small volumes and large volumes - bolus and drip
IM
Less rapid but longer lasting than IV
IM solutions - fast
IM suspension, oleaginous - slow
Point of injection as far as possible form major nerves and blood vessels
SC
Under the skin
For injecting small amounts of medication
1.3-2mL
Intradermal
Very small volume ~0.1mL
Usually done on the anterior forearm
Absorption from this site is slow
Used for immunological diagnostic tests (TB)
Types of injections according to USP
Injection
For injection
Injectable emulsion
Injectable suspension
For injectable suspension
Dispersions
Solutions
For injection
Dry solids that, upon addition of suitable vehicles, yield solutions conforming to the requirements for injections
Injectable emulsions
Liquid preparation of drug substance dissolved or dispersed in a suitable emulsion medium
Injectable suspension
Liquid preparation of solids suspended in suitable liquid medium
For injectable suspension
Dry solid, that upon addition of a suitable vehicle, yields a preparation conforming to the requirements for injectable suspensions
Selecting injection type
Stability - poor → dry, good → solution
Solubility - depending on solubility can make aqueous, oleaginous, emulsion, or suspension
Onset - fast → solution, slow → oleaginous/suspension
Duration - short → solution, long → oleaginous or suspension
Specific requirements for parenteral solution
Solvents or vehicles must meet special purity and safety standards
The use of excipients falls under specific guidelines and is restricted in certain parenteral. Coloring agents are prohibited.
Products are always sterilized, must meet sterility standards, and must not exceed allowable endotoxin limit.
Parenteral must meet standards for particulate matters
Must be prepared in environmentally controlled areas, under strict sterility standards
Parenteral must be packaged in special hermetic containers of specific and high quality
Each container is filled to column in slight excess of labeled volume to be withdrawn
The volume of injection permitted in multiple dose containers is restricted
Specific labeling requirements
Sterile powders are frequently packaged as lyophilized or freeze dried powders for ease of constitution
Active Drug in parenterals
Physical and chemical purity is important
Need special parenteral grade (sterility, pyrogen free, high chemical purity)
Strict conditions to prevent microbial contamination
Small packages to allow usage of the entire pack
Kinds of excipients in parenteral
Solvents in solutions, vehicles in dispersions
Solubilizers
buffers
antioxidants
preservatives
Tonicity contributors
Gases
Purpose of excipients in parenterals
Aid in production of the dosage form
Enhance physical, chemical, and microbial stability
Enhance safety of the product
Requirements for excipients in parenterals
Be non-toxic at the levels used
Not reduce product’s efficacy
Be compatible with other components of the parenteral preparation
Water for parenterals
Must be purified by distillation or reverse osmosis
Must be pyrogen free (<0.25)
Can not be labeled as sterile as it will be sterilized later
Needs to be collected in sterile pyrogen free containers
Limited to plant and manufacturing sites
Intended to be used within 24 hours after collection
Sterile water for parenteral injection
Not used in IV products because it is not isotonic
For reconstituting sterile powders to be used for parenteral administrations
For single dose container not larger than 1 liter
Endotoxin units <0.25
Bacteriostatic water for parenteral injection
Contains bacteriostatic agent
Name and concentration of agent should appear on label
No more than 30mL for multiple dose containers
Toxicity issue
not for use in neonates due to benzyl alcohol use
Sodium Chloride for Parenteral
Solvent
Sterile Isotonic solution (0.9%)
Sterile vehicle for solutions and suspensions for parenteral
No antimicrobial agents
Ringers injection
A sterile solution of NaCl, potassium chloride, and calcium chloride in water for injection
Lactated ringer injection
Has different quantities of the three salts in ringer injection, and it contains sodium lactate. Used as vehicle for electrolyte replenishment
Nonaqueous solvents for parenteral use requirements
Be non-toxic
Be non-irritating
Be non-sensitizing
Not have pharmacologic effect
Not degrade the drug
Have chemical and physical stability
Optimal viscosity for ease of injection
Fluidity over wide range of temperatures
Have sufficient high boiling point, low vapor pressure to allow heat sterilization
Be absorbed by body tissues
Not to be used in IV injections
Examples of nonaqueous solvents
Vegetable oils, glycerin, alcohols
Solubilizers for parenterals
Enhance solubility of the active ingredient
Examples of solubilizers
Ethyl alcohol
Polysorbate 20,40,60,80
Glycerin
Buffer capacity
Measures the ability of buffer solution to resist pH changes on addition an acid or a base. Important because drug properties can significantly be altered by pH changes.
What can cause pH changes
Glass
Dissolved gas
Released material from closures
Reactions within the product
Examples of buffers
Acetate, phosphate, citrate
Antioxidants
Protect the drug from oxidation
Replacing O2 with N2 or CO2
Reducing agents
Preferentially oxidize first
Ascorbic acid, sodium bisulfite
Blocking agents
Block the oxidation chain
Ascorbic acid esters, butyl hydroxy toluene (BHT)
Synergistic agents
Citric acid
Ascorbic acid
Chelating agents
Scavenge catalysts that accelerate oxidation
EDTA sodium
Preservatices
Prevent growth and kill microorganisms
USP requires them to be added to multiple dose containers to prevent growth of microorganisms regardless of method of sterilization employed
Examples of preservatives
Mercury and the cationic surface-active compounds
Chlorobutanol, cresol, phenol
Benzoyl alcohol
Tonicity contributors
Biologic systems are compatible with solutions having similar osmotic pressures, that is an equivalent number of dissolved species. Normal tonicity is 0.9%
Plastic container
Cheap, flexile, non-breakable, light weight
Must not react with the product
Product ingredients must not migrate into the plastic or vice versa
Must withstand sterilization process
Gas permeation is an issue
Examples of plastic containers
PVC bags, PP, HDPE, polyamide
type 1 Glass container
Borosilicate, most resistant
Type 2 glass container
Treated soda lime with sulfure, blocks UV
Type 3 container
Soda lime, most common
Containers for parenterals
Individual drug monographs will indicate which packaging is preferred. Consider size of dose. The size of multiple dose up to 30mL only to limit the number of entries.
Rubber closures
Plastic material
Prevents access of microorganisms into the product
Permit entry and withdrawal product without removing closure
Should not react with product
Caps
Hold stoppers in place
Usually made of aluminum
Ampules
Made of thin, medical grade glass
Used for materials incompatible with rubber or pvc components found in most vials